Cited 43 times in
Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.